References
- Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995;332:901–6
- Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynaecol Obstet 1981;152:765–72
- Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310–14
- Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet 1997;349:1864–7
- Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. JAMA 1996;276:1818–22
- Cox CE, Bass SS, McCann CR, Ku NN, Berman C, Durand K, et al. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. Annu Rev Med 2000;51:525–42
- Cody HS III, Fey J, Akhurst T, Fazzari M, Mazumdar M, Yeung H, et al. Complementarity of blue dye and isotope in sentinel node localization for breast: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13–19
- McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–6
- Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553–9
- Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528–35
- Singh-Ranger G, Mokbel K. Advances in breast oncology: the 2002 ASCO meeting. Curr Med Res Opin 2002;18: 401–6
- Veronesi U, Galimberti V, Zurrida S, et al. Sentinel node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454–8
- Gan S, Margarey C, Schwartz P, Papadatos G, Graham P, Vallentine J. Women’s choice between sentinel lymph node biopsy and axillary clearance. ANZ J Surg 2002;72:110–13
- Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–66
- Morton DL, Wen DR, Wong JH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9
- Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335–40
- Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271–8
- Motomura K, Inaji H, Komoike Y, Kasugai T, et al. Sentinel node biopsy in breast cancer patients with clinically negative lymph nodes. Breast Cancer 1999;6:259–62
- Recth A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol 1991;9:988–96
- Recth A. Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy. Semin Radiat Oncol 1999;9:269–74
- Burak WE Jr., Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23–7
- Brand TC, Sawyer MM, King TA, Bolton JS, Fuhrman GM. Understanding patterns of failure in breast cancer treatment argues for a more thorough investigation of axillary lymph nodes in node-negative patients. Am J Surg 2000;180:424–6